NWMP
AZN icon

Noble Wealth Management PBC’s AstraZeneca AZN Stock Holding History

Noble Wealth Management PBC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.1K Buy
13
+6
+86% +$1K ﹤0.01% 576
2026
Q2 		$1.33K Buy
+7
New +$1.32K ﹤0.01% 658

Other funds holding AZN

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
CCM
Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CNBT
Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Noble Wealth Management PBC's AZN Position: Q3 2026 in Review

Noble Wealth Management PBC increased its AstraZeneca (AZN) stake by 86% in Q3 2026, buying an estimated $1K and bringing the position to 13 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Noble Wealth Management PBC first reported a position in AZN in Q2 2026 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Noble Wealth Management PBC held 13 shares of AstraZeneca worth $2.1K as of Q3 2026.
  • Noble Wealth Management PBC bought 6 AstraZeneca shares in Q3 2026, an estimated $1K.
  • AstraZeneca made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #576 holding.
  • Noble Wealth Management PBC first reported a position in AstraZeneca in Q2 2026 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.